Global Takayasu Arteritis Registry (GITA)
Official title: Takayasu's Arteritis Global Registry
Run by Marmara University · NCT07558382 · Data updated 2026-11-12
The registry will collect past and ongoing medical information from people with Takayasu arteritis worldwide to see which treatments and patient features relate to better outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Marmara University Academic / other |
| Locations | 2 sites (Istanbul, Istanbul and 1 other locations) |
| Status | Recruiting |
| Started | August 5, 2025 |
| Main results expected | August 2035 |
| Study ends | August 2035 |
| Registry record updated | April 30, 2026 |
| Trial ID | NCT07558382 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
People who meet the ACR 1990 or ACR/EULAR 2021 criteria for Takayasu arteritis and can give informed consent (or have a legal representative) are eligible, whether enrolled retrospectively or after diagnosis moving forward.
✕Probably not a fit
Patients who do not meet the formal diagnostic criteria or who cannot or will not provide informed consent are not eligible and are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an international, multicenter, non-interventional registry that collects both retrospective and prospective longitudinal data on people with Takayasu arteritis. Participating centers upload routine demographic, clinical, laboratory, and imaging data plus details of diagnostic methods, management, and therapies. The project enables comparison of patient characteristics, treatment approaches, and prognoses across centers and regions. Data are gathered during usual clinical care and patients provide informed consent for inclusion.
Why it matters
Potential benefit: If successful, the registry could reveal patterns in disease course and treatment outcomes that help clinicians make better care decisions for people with Takayasu arteritis.
How similar studies have gone: Other vasculitis and Takayasu registries have provided useful natural history and outcome data, so this approach has precedent.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Each patient must fullfill the ACR 1990 or ACR/EULAR 2021 criteria for Takayasu arteritis. * Patients (or legally acceptable representatives of subjects enrolled) have to * provide informed and free agreement to participate in the study and to disclose any medical event to the investigator. The parents or legally acceptable representative and the adolescent subject must be willing and able to comply with the study protocol requirements for the duration of the study * freely sign written and dated informed consent after being duly informed of the nature, significance, and implications of the study; * be informed that the patient enrolled may withdraw consent at any time without prejudice to future medical care. Exclusion Criteria: Patients must be excluded from the study when the following criteria are observed: * The patient does not full-fill the ACR 1990 or ACR/EULAR 2021 criteria for Takayasu arteritis * informed consent/assent is not provided and signed
Where it's running
-
Marmara University School of Medicine
Istanbul, Istanbul, Turkey (Türkiye) Recruiting -
Marmara University School of Medicine
Istanbul, Istanbul, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Fatma Alibaz-Oner, Professor, MD
- Email: falibaz@gmail.com
- Phone: +902166574545
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Understanding patient and physician experiences and attitudes toward care in Takayasu arteritis.
This project asks adults with Takayasu arteritis and the doctors who treat them to complete online questionnaires to see what their experiences and care priorities are.
-
Registry for identifying biomarkers in Takayasu's Arteritis
This study is trying to find new markers in the blood that can help doctors diagnose and track the disease activity in people with Takayasu's arteritis.
-
Registry for women with vasculitis during pregnancy
This study is gathering information from pregnant women with vasculitis to understand their experiences and health outcomes during and after pregnancy.
-
Understanding the natural history and outcomes of systemic vasculitis
This study is trying to understand how systemic vasculitis affects people over time and what signs can help predict how the disease will progress, involving both patients with vasculitis and healthy volunteers.
-
One-time DNA analysis for vasculitis
This study is testing whether analyzing DNA from people with different types of vasculitis can help find genetic factors that increase the risk of these diseases and lead to better treatments.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.